Solenis has chosen its hometown of Wilmington as the site for a $40m research and development expansion.
In response to increasing market demand for its sustainability-focused products and expertise and with an eye toward long-term growth, Solenis will expand its R&D operations with a move to the 100,000 sq ft Building 713 at Chestnut Run Innovation and Science Park (CRISP). CRISP is a former DuPont campus that MRA Group is developing into a hub for a range of life sciences and advanced chemical companies.
The new CRISP facility will provide Solenis with 20,000 sq ft more lab space than the company currently has at its existing R&D center on Ashland’s Wilmington campus. In addition to more space, the larger, upgraded site will allow Solenis to add up to 46 new highly skilled Delaware jobs — including lab technicians, scientists and R&D supervisors — within the next three years.
“Solenis has deep roots in Delaware, so we are pleased to announce our continued commitment to growing in the state at CRISP,” said John Panichella, CEO, Solenis. “This investment of moving our Wilmington research center to a contemporary new location, in combination with our recently opened headquarters at Avenue North, allows us to continue to attract, retain and recruit the highest caliber of employees.”